

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1259, 2000-01, pp. : 21-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


The antiviral valaciclovir [`Valtrex'; Glaxo Wellcome] has been launched in Japan
Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. :


Lamivudine/abacavir [Kivexa; GlaxoSmithKline] has been launched in the UK and Germany
Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. :




Rabeprazole [`Pariet'] has been approved in a new indication in the European Union
Inpharma, Vol. 1, Iss. 1264, 2000-01 ,pp. :